Suppr超能文献

年龄调整后的合并症与局部晚期喉癌的生存。

Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

机构信息

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

出版信息

Head Neck. 2018 Sep;40(9):2060-2069. doi: 10.1002/hed.25200. Epub 2018 May 13.

Abstract

BACKGROUND

The purpose of this study was to quantify the relationship among age, pretreatment comorbidity, and survival outcomes in patients with locally advanced laryngeal cancer.

METHODS

Baseline comorbidity data were collected and age-adjusted Charlson Comorbidity Index (CCI) was calculated for each case. Kaplan-Meier and Cox proportional hazards modeling were used to determine associations with survival.

RESULTS

For 548 patients, with a median age of 59 years (range 31-91 years), 58% were treated with larynx preservation and the rest with total laryngectomy and adjuvant radiotherapy (RT). Two hundred thirty-eight patients (43%) had at least 1 comorbidity each. Cardiovascular diseases were the most common comorbidities (19%). The 5-year overall survival (OS) for patients with CCI ≤3 (n = 442) were superior to CCI >3 (n = 106; 60% vs 41%; P < .0001), although the 5-year disease-specific survival (DSS) rates were not significantly different. The 5-year noncancer CSS was better for age-adjusted CCI ≤3 (88% vs 67%; P < .0001).

CONCLUSION

The age-adjusted CCI is a significant predictor of noncancer CSS and OS for patients with locally advanced laryngeal cancer but is not associated with DSS.

摘要

背景

本研究旨在定量评估局部晚期喉癌患者的年龄、预处理合并症与生存结局之间的关系。

方法

收集基线合并症数据,并计算每位患者的年龄调整 Charlson 合并症指数(CCI)。采用 Kaplan-Meier 和 Cox 比例风险模型来确定与生存的关联。

结果

本研究纳入了 548 例患者,中位年龄为 59 岁(范围 31-91 岁),58%的患者接受了喉保留治疗,其余患者接受了全喉切除术和辅助放疗(RT)。238 例(43%)患者至少存在 1 种合并症。心血管疾病是最常见的合并症(19%)。CCI≤3(n=442)的患者 5 年总生存率(OS)优于 CCI>3(n=106;60% vs 41%;P<0.0001),尽管 5 年疾病特异性生存率(DSS)无显著差异。CCI≤3 的患者 5 年非癌症 CSS 更好(88% vs 67%;P<0.0001)。

结论

年龄调整的 CCI 是局部晚期喉癌患者非癌症 CSS 和 OS 的重要预测指标,但与 DSS 无关。

相似文献

2
Treatment, comorbidity and survival in stage III laryngeal cancer.III期喉癌的治疗、合并症与生存率
Head Neck. 2015 May;37(5):698-706. doi: 10.1002/hed.23653. Epub 2014 Sep 12.
5
Evaluation of Quality Metrics for Surgically Treated Laryngeal Squamous Cell Carcinoma.手术治疗喉鳞状细胞癌的质量指标评估
JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1154-1163. doi: 10.1001/jamaoto.2016.0657.
8
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.

引用本文的文献

本文引用的文献

7
Population-based study of competing mortality in head and neck cancer.基于人群的头颈部癌症竞争死亡研究。
J Clin Oncol. 2011 Sep 10;29(26):3503-9. doi: 10.1200/JCO.2011.35.7301. Epub 2011 Aug 15.
9
Predictors of competing mortality in advanced head and neck cancer.晚期头颈部癌症竞争死亡率的预测因素。
J Clin Oncol. 2010 Jan 1;28(1):15-20. doi: 10.1200/JCO.2008.20.9288. Epub 2009 Nov 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验